PL2192911T3 - Roślinny ekstrakt z konopi ubogich w THC do leczenia chorób - Google Patents

Roślinny ekstrakt z konopi ubogich w THC do leczenia chorób

Info

Publication number
PL2192911T3
PL2192911T3 PL08833341T PL08833341T PL2192911T3 PL 2192911 T3 PL2192911 T3 PL 2192911T3 PL 08833341 T PL08833341 T PL 08833341T PL 08833341 T PL08833341 T PL 08833341T PL 2192911 T3 PL2192911 T3 PL 2192911T3
Authority
PL
Poland
Prior art keywords
thc
diseases
treatment
cannabis extract
plant cannabis
Prior art date
Application number
PL08833341T
Other languages
English (en)
Inventor
Regina Kläger
Rudolph Kläger
Heinz Letzel
Original Assignee
Bionorica Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionorica Se filed Critical Bionorica Se
Publication of PL2192911T3 publication Critical patent/PL2192911T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/008—Preparations for oily skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL08833341T 2007-09-26 2008-09-26 Roślinny ekstrakt z konopi ubogich w THC do leczenia chorób PL2192911T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007046086A DE102007046086A1 (de) 2007-09-26 2007-09-26 Pflanzenextrakt aus THC-armen Cannabis zur Behandlung von Erkrankungen
PCT/DE2008/001581 WO2009039843A2 (de) 2007-09-26 2008-09-26 Pflanzenextrakt aus thc-armen cannabis zur behandlung von erkrankungen
EP08833341.4A EP2192911B8 (de) 2007-09-26 2008-09-26 Pflanzenextrakt aus thc-armen cannabis zur behandlung von erkrankungen

Publications (1)

Publication Number Publication Date
PL2192911T3 true PL2192911T3 (pl) 2019-05-31

Family

ID=40417936

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08833341T PL2192911T3 (pl) 2007-09-26 2008-09-26 Roślinny ekstrakt z konopi ubogich w THC do leczenia chorób

Country Status (7)

Country Link
US (5) US8337908B2 (pl)
EP (2) EP3446697A1 (pl)
DE (1) DE102007046086A1 (pl)
ES (1) ES2692875T3 (pl)
PL (1) PL2192911T3 (pl)
RU (2) RU2599028C2 (pl)
WO (1) WO2009039843A2 (pl)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11062795B2 (en) 2007-03-02 2021-07-13 Enigami Systems, Inc. Healthcare data system
WO2010150245A1 (en) * 2009-06-24 2010-12-29 Tikun Olam Ltd. Pharmaceutical and cosmeceutical compositions containing cannabis flower and seed extracts
PL388969A1 (pl) * 2009-09-04 2011-03-14 Instytut Włókien Naturalnych I Roślin Zielarskich Kompozycja na bazie olejku konopnego przeciwko patogenom, sposób wytwarzania kompozycji oraz zastosowanie wyciągu z wiech konopi do wytwarzania kompozycji przeciwko patogenom oraz do zwalczania patogenów grzybiczych
AT509000B1 (de) * 2009-10-23 2012-12-15 Rausch Peter Wasserlösliche zubereitungen von cannabinoiden und cannabispräparaten und deren anwendungen
CN103327830B (zh) * 2011-01-18 2016-04-27 克莱蒙特收藏公司 大麻植物汁液的获取方法以及生产饮料的用途
US20130274321A1 (en) * 2012-03-30 2013-10-17 Jon Newland Topical Compositions with Cannabis Extracts
CN102670722A (zh) * 2012-06-08 2012-09-19 吴光哲 一种用于治疗口腔溃疡的药物
WO2014145490A2 (en) 2013-03-15 2014-09-18 Biotech Institute, Llc Breeding, production, processing and use of specialty cannabis
US10441617B2 (en) 2013-03-15 2019-10-15 Biotech Institute, Llc Breeding, production, processing and use of medical cannabis
US9199960B2 (en) * 2013-05-02 2015-12-01 Frederick R. Ferri Method and apparatus for processing herbaceous plant materials including the cannabis plant
HK1232149A1 (zh) 2014-03-21 2018-01-05 St&T国际股份有限公司 大麻提取方法和组合物
US10319475B1 (en) 2014-06-13 2019-06-11 Enigami Systems, Inc. Method and apparatus for determining relationships between medications and symptoms
EP3160445B1 (en) 2014-06-26 2021-10-20 Island Breeze Systems Ca, LLC Mdi related products and methods of use
US20160000843A1 (en) * 2014-07-01 2016-01-07 MJAR Holdings, LLC High cannabidiol cannabis strains
WO2016029215A1 (en) * 2014-08-22 2016-02-25 Medipath, Inc. Compositions and methods for cannabinoid coatings for use in drug delivery
US20160143972A1 (en) * 2014-11-21 2016-05-26 Cannamark Inc. Method and apparatus for preparing a solid form of cannabinoid
WO2016105514A1 (en) 2014-12-23 2016-06-30 Biotech Institute, Llc A reliable and robust method for the analysis of cannabinoids and terpenes in cannabis
MA41299A (fr) * 2014-12-30 2017-11-07 Axim Biotechnologies Inc Solutions ophtalmiques pour le traitement du glaucome et de la conjonctivite
US10830780B2 (en) 2015-01-26 2020-11-10 Biotech Institute, Llc Apparatus and methods for sample analysis and classification based on terpenes and cannabinoids in the sample
US11040295B2 (en) 2015-02-06 2021-06-22 Joseph Francis Payack Method and apparatus for extracting plant oils using ethanol water
BG112018A (bg) * 2015-05-22 2016-11-30 "Побелч-Гле" Оод Метод за получаване на канабиноиден извлек от коноп
ES2595090B1 (es) * 2015-06-23 2017-09-05 José María FUNTANE VENDRELL Procedimiento de obtención de extractos vegetales a partir de tricomas glandulares y uso de dichos extractos para el tratamiento de enfermedades
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
WO2017063083A1 (en) * 2015-10-14 2017-04-20 Morris Johnson Control tower production method for crop fractions and derivatives
US10307447B2 (en) 2016-03-07 2019-06-04 Stephen Goldner Freeze dry process
LT6485B (lt) * 2016-04-04 2018-01-10 UAB "SatiMed" Topinė kompozicija su aktyviaisiais junginiais iš c. sativa ir c. officinalis skirta odos pažeidimų mažinimui
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
US9717683B1 (en) 2016-06-29 2017-08-01 Ep Pharma, Llc Low-temperature inhalation administration of cannabinoid entities
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US11273105B2 (en) 2017-06-16 2022-03-15 Sorse Technology Corporation Method for preparing solid forms of plant extract
US10668044B2 (en) 2017-06-27 2020-06-02 William H. Muscarella Blended cannabis compounds and methods of making the same
MX2019015673A (es) * 2017-06-30 2020-02-26 Creso Pharma Switzerland Gmbh Composicion de granulos veterinarios que contiene extracto de ca?amo.
CN107325881A (zh) * 2017-07-28 2017-11-07 云南汉木森生物科技有限责任公司 大麻花叶油的萃取方法及其大麻花叶油产品
US10272360B2 (en) 2017-08-05 2019-04-30 Priya Naturals, Inc. Phytochemical extraction system and methods to extract phytochemicals from plants including plants of the family Cannabaceae sensu stricto
US10500525B2 (en) 2017-08-17 2019-12-10 Curtis Hare Method for producing an extract from cannabis plant matter
CN107349157A (zh) * 2017-09-06 2017-11-17 云南汉木森生物科技有限责任公司 含火麻叶提取物的祛斑抗皱雪花膏及其制备方法
US10307392B2 (en) * 2017-10-21 2019-06-04 Alexander Kariman Compound and method for treatment of diseases and disorders
CN107811904B (zh) * 2017-10-27 2020-07-14 云南汉木森生物科技有限责任公司 抗炎祛斑雪花膏及其制备方法
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
HUE060229T2 (hu) 2018-02-20 2023-02-28 Mymd Pharmaceuticals Inc Genetikailag módosított cannabis sativa növények és módosított kannabinoid vegyületek a kábítószer-függõség és más rendellenességek kezelésére
WO2019177155A1 (ja) * 2018-03-16 2019-09-19 飯島　典子 カンナビジオール又はエッセンシャルオイルを含有するマッサージ用ロウソク
WO2019220324A2 (en) * 2018-05-14 2019-11-21 Buzzelet Development And Technologies Ltd Terpene-enriched cannabinoid compositions and uses thereof in the treatment of infectious conditions
US10639340B2 (en) 2018-06-18 2020-05-05 Eric Young Method of drying botanicals
US10897925B2 (en) 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
US20200035118A1 (en) 2018-07-27 2020-01-30 Joseph Pandolfino Methods and products to facilitate smokers switching to a tobacco heating product or e-cigarettes
WO2020077153A1 (en) 2018-10-10 2020-04-16 Canopy Holdings, LLC Synthesis of cannabigerol
US11243028B2 (en) 2018-12-14 2022-02-08 Fortunata, LLC Systems and methods of cryo-curing
US20210213082A1 (en) * 2019-10-24 2021-07-15 Fermented Farmer, LLC Botanical Synergistic Activated/Native and Equivalents Thereof
US11351476B2 (en) 2020-01-07 2022-06-07 Agrify Corporation Method for chemical separation of cannabinoids
US20210401922A1 (en) 2020-02-07 2021-12-30 Desert Harvest, Inc. Novel Cannabinoid Carrier Compositions Having Enhance Pharmacokinetic Properties And Methods of Use Thereof
US11524040B2 (en) 2020-08-24 2022-12-13 Charlotte's Web, Inc. Composition for the treatment of acne
WO2022133501A1 (en) * 2020-12-18 2022-06-23 The Regents Of The University Of California Wireless recording system-on-chip for distributed neural interface systems with inductive power delivery and uwb data transmission
WO2023283277A1 (en) * 2021-07-06 2023-01-12 Apex Medical Device Design, Llc Fermented uni-sourced nanoemulsion of nigella sativa or cannabis sativa for use in medical, cosmetic, and recreational indications with a method of its production and use
WO2023172982A2 (en) * 2022-03-08 2023-09-14 Trade Secret Chocolates Systems and methods for rehabilitating alcohol compositions and naturally fermentable herbs
US12604820B2 (en) 2023-03-29 2026-04-21 New West Genetics Inc. Cannabis variety NWG 4000
WO2025018830A1 (ko) * 2023-07-19 2025-01-23 토포랩 주식회사 대마 뿌리 추출물 및 복합가공을 통해 개선된 추출물을 유효성분으로 포함하는 염증성 질환의 예방 및 치료용 조성물
FR3161109A1 (fr) * 2024-04-15 2025-10-17 Ahaituki Sas Composition comprenant un macérat huileux de fleurs de chanvre et une émulsion de Pickering, préparation et utilisations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH680609A5 (pl) * 1989-10-30 1992-09-30 Hans Burger
US6912588B1 (en) * 1998-04-02 2005-06-28 Intel Corporation System and method for managing client requests in client-server networks
DE19833567C1 (de) * 1998-07-27 1999-08-12 Rose Broska Verfahren zur Herstellung von Lebensmitteln aus Hanf
US6403126B1 (en) * 1999-05-26 2002-06-11 Websar Innovations Inc. Cannabinoid extraction method
DE10051427C1 (de) 2000-10-17 2002-06-13 Adam Mueller Verfahren zur Herstellung eines Tetrahydrocannabinol- und Cannabidiol-haltigen Extraktes aus Cannabis-Pflanzenmaterial sowie Cannabis-Extrakte
CH695661A5 (de) 2001-03-06 2006-07-31 Forsch Hiscia Ver Fuer Krebsfo Pharmazeutische Zusammensetzung.
US6503532B1 (en) * 2001-04-13 2003-01-07 Murty Pharmaceuticals, Inc. Pharmaceutical composition containing tetrahydrocannabinol and a transdermal/transcutaneous delivery method thereof
US20030017216A1 (en) * 2001-07-23 2003-01-23 Schmidt Robert Gustav Isolation of herbal and cannabinoid medicinal extracts
EP1482917B1 (en) * 2002-02-01 2019-05-08 GW Pharma Limited Compositions comprising cannabidiolic acid for treatment of nausea, vomiting, emesis, motion sickness or like conditions
EP1559423A1 (en) 2004-02-02 2005-08-03 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Medicinal acidic cannabinoids
US20070060639A1 (en) 2005-09-09 2007-03-15 University Of Kentucky Compositions and methods for intranasal delivery of tricyclic cannabinoids

Also Published As

Publication number Publication date
RU2016121857A (ru) 2018-11-29
US10603344B2 (en) 2020-03-31
EP2192911B8 (de) 2018-12-19
US20100216872A1 (en) 2010-08-26
EP2192911A2 (de) 2010-06-09
WO2009039843A3 (de) 2009-10-01
RU2010116181A (ru) 2011-11-10
US20200155628A1 (en) 2020-05-21
RU2016121857A3 (pl) 2020-01-15
US20180125905A1 (en) 2018-05-10
EP2192911B1 (de) 2018-09-19
EP3446697A1 (de) 2019-02-27
DE102007046086A1 (de) 2009-04-09
US20130012575A1 (en) 2013-01-10
RU2599028C2 (ru) 2016-10-10
US20150044315A1 (en) 2015-02-12
ES2692875T3 (es) 2018-12-05
US8337908B2 (en) 2012-12-25
WO2009039843A2 (de) 2009-04-02

Similar Documents

Publication Publication Date Title
PL2192911T3 (pl) Roślinny ekstrakt z konopi ubogich w THC do leczenia chorób
HUE039731T2 (hu) l,3-difenilprop-2-én-l-on-származékok alkalmazása májbetegségek kezelésére
PL3354276T3 (pl) Kompozycje do leczenia zapalenia przewodu pokarmowego
BR112012004546A2 (pt) "terapêutica por proteínas ligantes dll4-ligantes"
HUE054495T2 (hu) Rák kezelésére szolgáló készítmény
BRPI0908026A2 (pt) Métodos para o tratamento de doenças do intestino
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
PL2442814T3 (pl) Bifidobacteria do leczenia cukrzycy i pokrewnych chorób
DK2121139T3 (da) Formulations for cancer treatment
ZA201001304B (en) Compositions for the treatment of neoplastic diseases
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK3135672T3 (da) Sammensætninger og fremgangsmåder til behandling af alkoholforbrugslidelser, smerter og andre sygdomme
BR112012001344A2 (pt) derivados de 17hidróxi-17-pentafluoroetil-estra-4,9(10)-dieno-11-arila, método de produção destes e uso destes para o tratamento de doenças
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
HRP20150052T1 (xx) Fungicidni pripravak i postupak za suzbijanje bolesti biljaka
HRP20160569T1 (hr) Boropeptidni inhibitori enteropeptidaze i njihove uporabe u liječenju pretilosti, pretjerane tjelesne težine i/ili bolesti povezane s abnormalnim metabolizmom masti
BRPI0911577A8 (pt) derivados espiro-indol para o tratamento de doenças parasíticas.
ATE523083T1 (de) Erhöhte pflanzenvitalität
DK2173831T3 (da) Brøndbehandling
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2022504T3 (da) Salve til behandling af hæmorider
IL202440A0 (en) Plant extract and its therapeutic use
FI20095600L (fi) Koostumus ihosairauksien hoitoa varten
PL2293805T3 (pl) Kompozycja do ssania, do leczenia chorób zapalnych jamy ustnej i gardłowej